Susquehanna International Group, LLP Veracyte, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $144,900 - $243,225	6,900 Added 36.13%	26,000 $884,000
Q2 2024 Aug 15, 2024	SELL	$18.86 - $23.55 $286,672 - $357,960	-15,200 Reduced 44.31%	19,100 $413,000
Q1 2024 May 07, 2024	SELL	$21.0 - $29.1 $235,200 - $325,920	-11,200 Reduced 24.62%	34,300 $760,000
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $13,804 - $20,076	-700 Reduced 1.52%	45,500 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $1.03 Million - $1.38 Million	46,200 New	46,200 $1.03 Million
Q1 2023 May 16, 2023	BUY	$20.58 - $27.89 $16,464 - $22,312	800 Added 5.3%	15,900 $354,000
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $575,656 - $1.13 Million	-37,600 Reduced 71.35%	15,100 $358,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $518,953 - $873,270	31,300 Added 146.26%	52,700 $875,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $129,780 - $247,968	8,400 Added 64.62%	21,400 $426,000
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $133,834 - $259,311	6,100 Added 88.41%	13,000 $358,000
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $99,736 - $148,316	-2,800 Reduced 28.87%	6,900 $321,000
Q2 2021 Aug 11, 2021	BUY	$32.94 - $56.62 $26,352 - $45,296	800 Added 8.99%	9,700 $388,000
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $84,493 - $154,622	-1,900 Reduced 17.59%	8,900 $478,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $42,237 - $80,444	1,300 Added 13.68%	10,800 $529,000
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $96,228 - $128,412	-3,600 Reduced 27.48%	9,500 $309,000
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $48,724 - $70,275	-2,500 Reduced 16.03%	13,100 $339,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $35,486 - $66,374	-2,200 Reduced 12.36%	15,600 $379,000
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $247,282 - $356,881	-11,900 Reduced 40.07%	17,800 $497,000
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $181,412 - $235,068	7,600 Added 34.39%	29,700 $713,000
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $64,090 - $82,824	-2,900 Reduced 11.6%	22,100 $630,000
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $33,600 - $72,128	2,800 Added 12.61%	25,000 $626,000
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $212,010 - $280,608	22,200 New	22,200 $212,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$280 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$278 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$181 Million
0.27% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.92M
Shares

$177 Million
1.59% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$152 Million
0.03% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.57B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account